BioWorld Science

RSS

Novel polycomb protein EED inhibitors identified at Novartis

Jan. 10, 2018

Axsome Therapeutics announces results of IDMC interim analysis of COAST-1 and CREATE-1 trials

Jan. 10, 2018

Lenvima plus Keytruda obtains FDA breakthrough therapy designation in RCC

Jan. 10, 2018

Machine learning framework allows 99% accurate ligand binding predictions

Jan. 10, 2018

TG Therapeutics obtains rights to Jiangsu Hengrui's BTK inhibitor program

Jan. 10, 2018

The Medicines Co. closes sale of infectious disease business unit to Melinta Therapeutics

Jan. 10, 2018

Baxter buys two hemostasis products from Mallinckrodt

Jan. 10, 2018

Novartis patents novel HBsAg secretion inhibitors

Jan. 10, 2018

Patient enrollment ongoing in phase I trial of the GBM vaccine candidate VBI-1901

Jan. 10, 2018

New phase II clinical data presented for radioiodinated tositumomab in NHL

Jan. 9, 2018